Results 221 to 230 of about 19,018,457 (307)

Geographic analysis of the variation in the incidence of ADHD in a country with free access to healthcare: a Danish cohort study. [PDF]

Int J Health Geogr, 2015
Madsen KB, Ersbøll AK, Olsen J, Parner E, Obel C.   +4 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Dakota Access Pipeline Project, Dakota Access, LLC, cultural avoidance sites, Thorp Cemetery

PCN Review Area 82 s j Ji ■k^ ■ •■ ronu-i OO Cjf . o OO Site ID: Thorp Cemetery Site Avoidance Plan Distance to Centerline: 68ft Distance to Workspace: 31ft Notes: Barrier fencing would be installed along the ROW to separate the site from the ...
Dakota Access, LLC;
core  

Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases. [PDF]

PLoS One, 2016
Cadier B, Durand-Zaleski I, Thomas D, Chevreul K.   +3 more
europepmc   +1 more source

What is Open Access (vs. Free Access)?

Archivalia, 2007
openaire   +2 more sources

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

The ACT-i-Pass study protocol: How does free access to recreation opportunities impact children's physical activity levels? [PDF]

BMC Public Health, 2015
Gilliland JA, Clark AF, Tucker P, Prapavessis H, Avison W, Wilk P.   +5 more
europepmc   +1 more source

Free Access to Science

netbib, 2004
openaire   +2 more sources

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Clinical trial on the effects of a free-access acidified milk replacer feeding program on the health and growth of dairy replacement heifers and veal calves. [PDF]

J Dairy Sci, 2017
Todd CG, Leslie KE, Millman ST, Bielmann V, Anderson NG, Sargeant JM, DeVries TJ.   +6 more
europepmc   +1 more source